Abstract:Abstract Background Studies had shown many diseases affect the stability of human microbiota, but how this relates to benign prostatic hyperplasia (BPH) has not been well understood. Hence, this study aimed to investigate the regulation of BPH on gut microbiota composition and metabonomics. Methods We analyzed gut samples from rats with BPH and healthy control rats, the gut microbiota composition and metabonomics were detected by 16S rDNA sequencing and liquid chromatography tandem mass spectrometry (LC–MS/MS). Results High-throughput sequencing results showed that gut microbiota beta-diversity increased ( P < 0.01) in the BPH group vs. control group. Muribaculaceae ( P < 0.01), Turicibacteraceae ( P < 0.05), Turicibacter ( P < 0.01) and Coprococcus ( P < 0.01) were significantly decreased in the BPH group, whereas that of Mollicutes ( P < 0.05) and Prevotella ( P < 0.05) were significantly increased compared with the control group. Despite profound interindividual variability, the levels of several predominant genera were different. In addition, there were no statistically significant differences in several bacteria. BPH group vs. control group: Firmicutes (52.30% vs. 57.29%, P > 0.05), Bacteroidetes (46.54% vs. 41.64%, P > 0.05), Clostridia (50.89% vs. 54.66%, P > 0.05), Ruminococcaceae (25.67% vs. 20.56%, P > 0.05). LC–MS/MS of intestinal contents revealed that differential metabolites were mainly involved in cellular processes, environmental information processing, metabolism and organismal systems. The most important pathways were global and overview maps, lipid metabolism, amino acid metabolism, digestive system and endocrine system. Through enrichment analysis, we found that the differential metabolites were significantly enriched in metabolic pathways, steroid hormone biosynthesis, ovarian steroidogenesis, biosynthesis of unsaturated fatty acids and bile secretion. Pearson correlation analysis ( R = 0.94) showed that there was a strong correlation between Prevotellaceae , Corynebacteriaceae , Turicibacteraceae , Bifidobacteriaceae and differential metabolites. Conclusion Our findings suggested an association between the gut microbiota and BPH, but the causal relationship between the two groups is unclear. Thus, further studies are warranted to elucidate the potential mechanisms and causal relationships between BPH and gut microbiota.

Exploring the Association between Gut and Urine Microbiota and Prostatic Disease including Benign Prostatic Hyperplasia and Prostate Cancer Using 16S rRNA Sequencing

Urinary Microbiota In Patients With Prostate Cancer And Benign Prostatic Hyperplasia

Effect of Hypertension on Bacteria Composition of Prostate Biopsy in Patients with Benign Prostatic Hyperplasia and Prostate Cancer in PSA Grey-Zone.

A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis

Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China

Alterations of gut microbiota diversity, composition and metabonomics in testosterone-induced benign prostatic hyperplasia rats

Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System

Associations between gut microbiota and three prostate diseases: a bidirectional two-sample Mendelian randomization study

Metagenomic and Metatranscriptomic Analysis of Human Prostate Microbiota from Patients with Prostate Cancer

Preliminary study of the effect of gut microbiota on the development of prostatitis

Effects of gut microbiota on prostatic cancer: a two-sample Mendelian randomization study

Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer

The Microbiome of Prostate Fluid Is Associated With Prostate Cancer.

Causality investigation among gut microbiota, immune cells, and prostate diseases: a Mendelian randomization study

Gut Microbiota Disorders in Obesity-Associated Benign Prostatic Hyperplasia in Rats

Alterations in urinary microbiota composition in urolithiasis patients: insights from 16S rRNA gene sequencing

Microbiome analysis reveals the inducing effect of Pseudomonas on prostatic hyperplasia via activating NF-κB signalling

Prostate Tissue Microbiome in Patients with Prostate Cancer: A Systematic Review

Periodontitis relates to benign prostatic hyperplasia via the gut microbiota and fecal metabolome

Dysbiosis signatures of the microbial profile in tissue from bladder cancer.

Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer